In order to reconstruct the clonal architecture of the stem cell compartment during MPN evolution, peripheral blood (PB) CD34+ cells were analyzed at three different stages of the disease: at diagnosis (T1), during the accelerated phase (T2), and in the AML phase (T3). Here, CD34 is linked to myeloproliferative disorder.